18 December 2017

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

18 December 2017 | n=48

  1. Reidy WJ, Rabkin M, Syowai M, Schaaf A, et al.
    Patient- and program-level monitoring of differentiated service delivery for HIV: a pragmatic and parsimonious approach is needed.
    AIDS 2017.

  2. Mountford J, Octaviana F, Estiasari R, Setiawan DD, et al.
    Ex vivo expression of chemokine receptors on cells surrounding cutaneous nerves in patients with HIV-associated sensory neuropathy.
    AIDS 2017.

  3. Neogi U, Singh K, Aralaguppe SG, Rogers LC, et al.
    Ex vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV-1 non-B subtypes.
    AIDS 2017.

  4. Gao N, Wang W, Wang C, Gu T, et al.
    Development of broad neutralization activity in SHIV-infected rhesus macaques after long-term infection.
    AIDS 2017.

  5. Sadanand S, Das J, Chung AW, Schoen MK, et al.
    Temporal variation in HIV-specific IgG subclass Abs during acute infection differentiates spontaneous controllers from chronic progressors.
    AIDS 2017.

  6. Mccomsey GA, Lupo S, Parks D, Poggio MC, et al.
    Switch from tenofovir disoproxil fumarate combination to dolutegravir plus rilpivirine improves parameters of bone health.
    AIDS 2017.

  7. Boser AS, Bidaud B, Maues S, Guiraud N, et al.
    Addressing HIV on the French Guyanese-Brazilian border: no choice but collaboration!
    AIDS 2017.

  8. Altekruse SF, Shiels MS, Modur SP, Land SR, et al.
    Cancer burden attributable to cigarette smoking among HIV-infected people in North America.
    AIDS 2017.

  9. Coghill AE, Schenk JM, Mahkoul Z, Orem J, et al.
    Omega-3 decreases interleukin-6 levels in HIV and HHV-8 co-infected patients: results from a randomized supplementation trial in Uganda.
    AIDS 2017.

  10. Cordova D, Heinze J, Hsieh HF, Mistry R, et al.
    Are trajectories of psychosocial risk in adolescence linked to HIV vulnerability in emerging and young adulthood? an eighteen-year longitudinal study.
    AIDS 2017.

  11. McMahon CN, Petoumenos K, Hesse K, Carr A, et al.
    Eleven-year incident glucose disorders in treated HIV-infection. The St Vincent's HIV and Diabetes Study.
    AIDS 2017.

  12. Nguyen VK, Greenwald ZR, Trottier H, Cadieux M, et al.
    Incidence of sexually transmitted infections before and after Pre-Exposure Prophylaxis for HIV: a cohort study.
    AIDS 2017.

  13. Amedee A, Phillips B, Jensen K, Robichaux S, et al.
    Early sites of virus replication after oral SIVmac251 infection of infant macaques: implications for pathogenesis.
    AIDS Res Hum Retroviruses 2017.

  14. Rodgers MA, Vallari AS, Yamaguchi J, Holzmayer V, et al.
    ARCHITECT HIV Combo Ag/Ab(R) and RealTime(R) HIV-1 assays detect diverse HIV strains in clinical specimens.
    AIDS Res Hum Retroviruses 2017.

  15. Cary DC, Peterlin BM.
    Natural products and HIV/AIDS.
    AIDS Res Hum Retroviruses 2017.

  16. Tucker JD, Zhang A, Zhao Y.
    HIV Cure Research Crowdsourcing: An Author Response.
    AIDS Res Hum Retroviruses 2017.

  17. Kong D, Wang Y, Wang C, Liang S, et al.
    Identification of a novel HIV-1 unique recombinant form between B, CRF01_AE and CRF07_BC in men who have sex with men in Guangxi, China.
    AIDS Res Hum Retroviruses 2017.

  18. Seang S, Kelesidis T, Huynh D, Park S, et al.
    Low levels of endothelial progenitor cells and their association with systemic inflammation and monocyte activation in older HIV-infected men.
    AIDS Res Hum Retroviruses 2017.

  19. Raymond S, Nicot F, Pallier C, Bellecave P, et al.
    Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen.
    Clin Infect Dis 2017.

  20. Moulignier A, Savatovsky J, Assoumou L, Lescure FX, et al.
    Silent Cerebral Small-Vessel Disease Twice as Prevalent in Middle-Aged Well-Controlled cART-Treated HIV-Infected Individuals Than HIV-Uninfected Individuals.
    Clin Infect Dis 2017.

  21. Moore DJ, Jain S, Dube MP, Daar ES, et al.
    Randomized Controlled Trial of Daily Text Messages To Support Adherence to PrEP In At-Risk for HIV Individuals: The TAPIR Study.
    Clin Infect Dis 2017.

  22. Crowell TA, Colby DJ, Pinyakorn S, Fletcher JLK, et al.
    Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.
    Clin Infect Dis 2017.

  23. Rickles M, Rebeiro PF, Sizemore L, Juarez P, et al.
    Tennessee's In-State Vulnerability Assessment for a 'Rapid Dissemination of HIV or HCV Infection' Event Utilizing Data about the Opioid Epidemic.
    Clin Infect Dis 2017.

  24. Flynn PM, Taha TE, Cababasay M, Fowler MG, et al.
    Prevention of Hiv-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in Hiv-1-Infected Women with High Cd4 Cell Count (Impaact Promise): A Ran
    J Acquir Immune Defic Syndr 2017.

  25. Morgan Freiman J, Jacobson KR, Muyindike WR, Robert Horsburgh C, et al.
    Isoniazid Preventive Therapy for People with HIV who are Heavy Alcohol Drinkers in High TB/HIV Burden Countries: a Risk-Benefit Analysis.
    J Acquir Immune Defic Syndr 2017.

  26. Siedner MJ, Hunt PW.
    All About the Albumin? Prognostic Capacity of Serum Albumin in Patients With Treated HIV Infection.
    J Infect Dis 2017.

  27. Ronit A, Sharma S, Baker JV, Mngqibisa R, et al.
    Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study.
    J Infect Dis 2017.

  28. King CC, Ellington SR, Davis NL, Coombs RW, et al.
    Prevalence, Magnitude, and Correlates of HIV-1 Genital Shedding in Women on Antiretroviral Therapy.
    J Infect Dis 2017.

  29. Hayashi K, Dong H, Kerr T, Dobrer S, et al.
    Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.
    J Infect Dis 2017.

  30. Sivro A, McKinnon LR.
    Mucosal HIV Shedding During ART.
    J Infect Dis 2017.

  31. Ngobeni R, Samie A, Moonah S, Watanabe K, et al.
    Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia.
    J Infect Dis 2017.

  32. Ranganath N, Sandstrom TS, Burke Schinkel SC, Cote SC, et al.
    The oncolytic virus, MG1, targets and eliminates latently HIV-1-infected cells: implications for an HIV cure.
    J Infect Dis 2017.

  33. Ajaykumar A, Soudeyns H, Kakkar F, Brophy J, et al.
    Leukocyte telomere length at birth and during the early life of HIV-exposed uninfected children following in utero exposure to antiretrovirals.
    J Infect Dis 2017.

  34. Vergara-Ortega DN, Sevilla-Reyes EE, Herrera-Ortiz A, Torres-Ibarra L, et al.
    J Med Virol 2017.

  35. Hraber P, Rademeyer C, Williamson C, Seaman MS, et al.
    Correction for Hraber et al., "Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments".
    J Virol 2018;92.

  36. Jones AT, Chamcha V, Kesavardhana S, Shen X, et al.
    A trimeric HIV-1 envelope gp120 immunogen induces potent and broad anti-V1V2 loop antibodies against HIV-1 in rabbits and rhesus macaques.
    J Virol 2017.

  37. Morger D, Zosel F, Buhlmann M, Zuger S, et al.
    The three-fold axis of the HIV-1 capsid lattice is the species-specific binding interface for TRIM5alpha.
    J Virol 2017.

  38. Chikata T, Van Tran G, Murakoshi H, Akahoshi T, et al.
    HLA class I-mediated HIV-1 control in Vietnamese infected with HIV-1 subtype A/E.
    J Virol 2017.

  39. Cohen YZ, Lorenzi JCC, Seaman MS, Nogueira L, et al.
    Neutralizing activity of broadly neutralizing anti-HIV-1 antibodies against clade B clinical isolates produced in peripheral blood mononuclear cells.
    J Virol 2017.

  40. Schouest B, Weiler AM, Janaka SK, Myers TA, et al.
    Maintenance of AP-2 Dependent Functional Activities of Nef Restricts Pathways of Immune Escape from CD8 T Lymphocyte Responses.
    J Virol 2017.

  41. Qualls ZM, Choudhary A, Honnen W, Prattipati R, et al.
    Identification of novel structural determinants in MW965 Env that regulate the neutralization phenotype and conformational masking potential of primary HIV-1 isolates.
    J Virol 2017.

  42. Bernardo EL, Fuente-Soro L, Lopez-Varela E, Naniche D, et al.
    Anonymity in HIV testing: implications for public health.
    Lancet 2017;390:2546.

  43. Cohen SD, Kopp JB, Kimmel PL.
    Kidney Diseases Associated with Human Immunodeficiency Virus Infection.
    N Engl J Med 2017;377:2363-2374.

  44. Baker AN, Bayer AM, Viani RM, Kolevic L, et al.
    Morbidity and Mortality of a Cohort of Peruvian HIV-Infected Children 2003-2012.
    Pediatr Infect Dis J 2017.

  45. Bucek A, Leu CS, Benson S, Warne P, et al.
    Psychiatric Disorders, Antiretroviral Medication Adherence, and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults.
    Pediatr Infect Dis J 2017.

  46. Archary M, Mcllleron H, Bobat R, La Russa P, et al.
    Population Pharmacokinetics of Lopinavir in Severely Malnourished HIV Infected Children and the Effect on Treatment Outcomes.
    Pediatr Infect Dis J 2017.

  47. Seth A, Malhotra RK, Gupta R, Chandra J, et al.
    Effect of Antiretroviral Therapy on Growth Parameters of Children With HIV Infection.
    Pediatr Infect Dis J 2018;37:85-89.

  48. Desai M, Field N, Grant R, McCormack S, et al.
    Recent advances in pre-exposure prophylaxis for HIV.
    BMJ 2017;359:j5011.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

21 January 2019

14 January 2019

07 January 2019

30 December 2018

23 December 2018

18 December 2017

Multidisciplinary Journal Club

  1. Morch LS, Skovlund CW, Hannaford PC, Iversen L, et al.
    Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    N Engl J Med. 2017;377:2228-2239.

  2. Molyneux DH, Savioli L, Engels D.
    Neglected tropical diseases: progress towards addressing the chronic pandemic.
    Lancet. 2017;389:312-325.

  3. Williams R, Alexander G, Armstrong I, Baker A, et al.
    Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
    Lancet. 2017 Nov 28. pii: S0140-6736(17)32866.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016